Publikationen 2021
Gender differences in response to biologicals. Women fare worse across inflammatory arthritis diseases – data from BIOREG EULAR 2021 und ÖGR 2021
E. Loibner, V. Ritschl, P. Spellitz, G. Eichbauer-Sturm, J. Zwerina, M. Herold, M. Stetter, R. Puchner, H. Hitzelhammer, F. Singer, B.F. Leeb, R. Fritsch-Stork Link...
Der Rheumatologe Burkhard Leeb spricht mit Springer-Redakteurin Tanja Fabsits
Link zum Podcast: https://www.springermedizin.at/podcasts/kinderhospiz/19194568...
Januskinase Inhibitors to Treat Rheumatoid Arthritis: Real World Data Match Clinical Trial Results. An Evaluation by BioReg, the Austrian Registry for Biologicals, Biosimilars, and Targeted Synthetic DMARDS in the Treatment of Inflammatory Rheumatic Diseases; Rheumatology: Current research(Sunnyvale), Vol.11 Iss. 5,No1000288 2021
Leeb B.F., Spellitz P., Eichbauer-Sturm G., Herold M., Stetter M., Puchner R., Singer F., Fritsch-Stork R. Link zum PDF: Januskinase Inhibitors to Treat Rheumatoid Arthritis...
19. Wachauer Rheumatag, 24.04.2021, online Präsentation „Wie geht es Österreichs Rheumatikern? BioReg 8.3.2020 – 8.3.2021“
von Burkhard F. Leeb...